Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors

Miriam C. Souroujon, Prasanta K. Maiti, Tali Feferman, Sin Hyeog Im, Lily Raveh, Sara Fuchs

Research output: Contribution to journalArticlepeer-review

Abstract

We have shown that mucosal administration of recombinant fragments corresponding to the human acetylcholine receptor (AChR) α subunit suppresses chronic ongoing experimental autoimmune myasthenia gravis (EAMG) in rats. Treated animals exhibit a Th1 to Th2/Th3 shift in their cytokine profile and downregulation of costimulatory factors. However, application of a xenogeneic recombinant fragment may have limitations when considered as a possible approach for the treatment of MG in humans. We therefore tested the potential of a syngeneic fragment and of long synthetic peptides to suppress EAMG. We found that a syngeneic fragment corresponding to the extracellular region of the rat AChR α subunit was as effective as the formerly described human xenogeneic fragment in suppressing ongoing EAMG. This is encouraging in view of the potential use of mucosally administered recombinant AChR fragments for the treatment of MG in humans. However, in severely affected individuals, this antigen-specific approach may need to be supported by direct modulation of cytokines and costimulatory factors known to be involved in the pathogenesis of EAMG. To test the potential of this approach, myasthenic rats were injected by antibodies either to the proinflammatory cytokine IL-18 or to the costimulatory factor CD40L. These treatments act via different mechanisms, but both lead to the alleviation of clinical symptoms even when given at the chronic phase of EAMG. We suggest that antagonists to key cytokines and/or costimulatory factors be used to augment antigen-specific treatments of myasthenia such as mucosal administration of AChR recombinant fragments.

Original languageEnglish
Pages (from-to)533-536
Number of pages4
JournalAnnals of the New York Academy of Sciences
Volume998
DOIs
StatePublished - 2003

Keywords

  • Costimulatory factors
  • Cytokines
  • Mucosal tolerance
  • Suppression of ongoing EAMG
  • Syngeneic recombinant fragments
  • Synthetic peptides

Fingerprint

Dive into the research topics of 'Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors'. Together they form a unique fingerprint.

Cite this